Welcome to the Oncology Brothers podcast! In this episode of our *Partners in Practice* series, we dived into the world of multiple myeloma treatment. We had the opportunity to engage with the dedicated team from UCSF, including Dr. Ajai Chari, a myeloma specialist, nurse practitioner Samantha Shenoy, NP, and clinical nurse Jenny Truong, RN.
In this insightful discussion, we covered:
- The current standard of care for newly diagnosed multiple myeloma patients, focusing on quadruple therapy
- The role of anti-CD38 therapies like daratumumab and isatuximab in treatment regimens
- Patient expectations regarding side effects and the importance of supportive care
- The dynamics of teamwork in oncology, emphasizing communication and collaboration among healthcare professionals
Whether you're a healthcare professional, a patient, or simply interested in the latest advancements in cancer care, this episode offers valuable insights into the complexities of treating multiple myeloma.
Listen us on:
Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o
Follow us on social media:
- X/Twitter: https://x.com/oncbrothers
- Instagram: https://www.instagram.com/oncbrothers
- Website: https://oncbrothers.com/
Don't forget to like, subscribe, and hit the notification bell for more episodes from the Oncology Brothers!
#MultipleMyeloma, #QuadTherapy, #Daratumumab, #Isatuximab, #OncologyBrothers
